These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12676774)

  • 21. Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
    Hoffman H; Rice C; Skordalakes E
    J Biol Chem; 2017 Mar; 292(11):4593-4601. PubMed ID: 28154186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomerase gene mutation screening in Chinese patients with aplastic anemia.
    Han B; Liu B; Cui W; Wang X; Lin J; Zhao Y
    Leuk Res; 2010 Feb; 34(2):258-60. PubMed ID: 19942288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human telomere disease due to disruption of the CCAAT box of the TERC promoter.
    Aalbers AM; Kajigaya S; van den Heuvel-Eibrink MM; van der Velden VH; Calado RT; Young NS
    Blood; 2012 Mar; 119(13):3060-3. PubMed ID: 22323451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dyskeratosis congenita and telomerase.
    Bessler M; Wilson DB; Mason PJ
    Curr Opin Pediatr; 2004 Feb; 16(1):23-8. PubMed ID: 14758110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of TERC haploinsufficiency on the inheritance of telomere length.
    Goldman F; Bouarich R; Kulkarni S; Freeman S; Du HY; Harrington L; Mason PJ; Londoño-Vallejo A; Bessler M
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17119-24. PubMed ID: 16284252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita.
    Kirschner M; Maurer A; Wlodarski MW; Ventura Ferreira MS; Bouillon AS; Halfmeyer I; Blau W; Kreuter M; Rosewich M; Corbacioglu S; Beck J; Schwarz M; Bittenbring J; Radsak MP; Wilk CM; Koschmieder S; Begemann M; Kurth I; Schemionek M; Brümmendorf TH; Beier F
    Leukemia; 2018 Aug; 32(8):1762-1767. PubMed ID: 29749397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and laboratory characteristics in patients of myelodysplastic syndrome with PNH clones].
    Li Y; Qin T; Xu Z; Zhang Y; Wang J; Li B; Fang L; Pan L; Hu N; Zhang H; Qu S; Liu J; Wang H; Xiao Z
    Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):313-7. PubMed ID: 27093995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic Mutations in Aplastic Anemia.
    Mufti GJ; Marsh JCW
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):595-607. PubMed ID: 30047413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of immunogenetic polymorphisms in bone marrow failure syndromes.
    Serio B; Selleri C; Maciejewski JP
    Mini Rev Med Chem; 2011 Jun; 11(6):544-52. PubMed ID: 21561401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A spectrum of severe familial liver disorders associate with telomerase mutations.
    Calado RT; Regal JA; Kleiner DE; Schrump DS; Peterson NR; Pons V; Chanock SJ; Lansdorp PM; Young NS
    PLoS One; 2009 Nov; 4(11):e7926. PubMed ID: 19936245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation in PRDM8 is indicative for dyskeratosis congenita.
    Weidner CI; Lin Q; Birkhofer C; Gerstenmaier U; Kaifie A; Kirschner M; Bruns H; Balabanov S; Trummer A; Stockklausner C; Höchsmann B; Schrezenmeier H; Wlodarski M; Panse J; Brümmendorf TH; Beier F; Wagner W
    Oncotarget; 2016 Mar; 7(10):10765-72. PubMed ID: 26909595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gene mutations in bone marrow failure syndromes].
    Yoshizato T; Makishima H
    Rinsho Ketsueki; 2016; 57(12):2519-2525. PubMed ID: 28090021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia.
    Kirwan M; Walne AJ; Plagnol V; Velangi M; Ho A; Hossain U; Vulliamy T; Dokal I
    Am J Hum Genet; 2012 May; 90(5):888-92. PubMed ID: 22541560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of mutations of the human telomerase RNA gene (hTERC) in myelodysplastic syndrome.
    Ohyashiki K; Shay JW; Ohyashiki JH
    Haematologica; 2005 May; 90(5):691. PubMed ID: 15921388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
    Ishihara S; Nakakuma H; Kawaguchi T; Nagakura S; Horikawa K; Hidaka M; Asou N; Mitsuya H
    Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
    de la Fuente J; Dokal I
    Pediatr Transplant; 2007 Sep; 11(6):584-94. PubMed ID: 17663679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.
    Durrani J; Maciejewski JP
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):97-104. PubMed ID: 31808900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomeres and marrow failure.
    Calado RT
    Hematology Am Soc Hematol Educ Program; 2009; ():338-43. PubMed ID: 20008219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between aplastic anaemia and mutations in telomerase RNA.
    Vulliamy T; Marrone A; Dokal I; Mason PJ
    Lancet; 2002 Jun; 359(9324):2168-70. PubMed ID: 12090986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased frequency of somatic mutations at glycophorin A loci in patients with aplastic anaemia, myelodysplastic syndrome and paroxysmal nocturnal haemoglobinuria.
    Hattori H; Machii T; Ueda E; Shibano M; Kageyama T; Kitani T
    Br J Haematol; 1997 Aug; 98(2):384-91. PubMed ID: 9266937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.